Literature DB >> 18465156

Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review : Review of mfERG ring ratios in Plaquenil toxicity.

Jonathan S Lyons1, Matthew L Severns.   

Abstract

Multifocal ERG ring ratios provide a sensitive and objective method to detect ocular toxicity in patients taking hydroxychloroquine (Plaquenil). In order to measure ring ratios, the average mfERG amplitude was calculated for each of five concentric rings of a 61-hexagon mfERG. The age-corrected amplitude of the central hexagon (R(1)) and the ratios of R(1) to each of the successive rings (R(1)/R(2), R(1)/R(3), etc.) were then computed. Normative values for ring ratios were established from a population of 67 normal controls. In the study population, a ring was considered abnormal if it was above the 99% confidence limits for the normal population. The technique was evaluated on 131 eyes of 62 patients taking Plaquenil for a variety of conditions including rheumatoid arthritis, systemic lupus erythematosus, and Sjögren's syndrome. Patients who had taken Plaquenil for an extended period showed a higher incidence of retinal toxicity, regardless of the condition for which they were taking the drug. Among patients who had taken a cumulative dose of less than 1,250 g, 7 of 67 eyes (10%) showed a characteristic mfERG defect, while in patients with a cumulative dosage of 1,250 g or more, 26 of 64 eyes (41%) showed one of these defects. In at least one patient, the technique was able to detect the early onset of Plaquenil toxicity followed by reversal of the toxic effects after the medication was discontinued. It appears appropriate to recommend that mfERG testing be done on all patients on Plaquenil therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465156     DOI: 10.1007/s10633-008-9130-0

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  15 in total

1.  Hydroxychloroquine retinopathy.

Authors:  R K Maturi; J C Folk; B Nichols; T T Oetting; R H Kardon
Journal:  Arch Ophthalmol       Date:  1999-09

2.  Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice.

Authors:  G D Levy; S J Munz; J Paschal; H B Cohen; K J Pince; T Peterson
Journal:  Arthritis Rheum       Date:  1997-08

Review 3.  Ocular safety of hydroxychloroquine.

Authors:  H N Bernstein
Journal:  Ann Ophthalmol       Date:  1991-08

4.  Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.

Authors:  Jonathan S Lyons; Matthew L Severns
Journal:  Am J Ophthalmol       Date:  2007-03-06       Impact factor: 5.258

5.  Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.

Authors:  Timothy Y Y Lai; Wai-Man Chan; Haitao Li; Ricky Y K Lai; Dennis S C Lam
Journal:  Am J Ophthalmol       Date:  2005-11       Impact factor: 5.258

6.  Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.

Authors:  D S Finbloom; K Silver; D A Newsome; R Gunkel
Journal:  J Rheumatol       Date:  1985-08       Impact factor: 4.666

7.  Hydroxychloroquine therapy in massive total doses without retinal toxicity.

Authors:  M W Johnson; A K Vine
Journal:  Am J Ophthalmol       Date:  1987-08-15       Impact factor: 5.258

8.  Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.

Authors:  Raj K Maturi; Minzhong Yu; Richard G Weleber
Journal:  Arch Ophthalmol       Date:  2004-07

9.  Effects of reference electrode location on monopolar-derived multifocal electroretinograms in cynomolgus monkeys.

Authors:  Charlene B Y Kim; James N VerHoeve; Paul L Kaufman; T Michael Nork
Journal:  Doc Ophthalmol       Date:  2006-03-02       Impact factor: 1.854

10.  ISCEV guidelines for clinical multifocal electroretinography (2007 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2007-10-31       Impact factor: 2.379

View more
  30 in total

Review 1.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  The mfERG response topography with scaled stimuli: effect of the stretch factor.

Authors:  Charlotte M Poloschek; Michael Bach
Journal:  Doc Ophthalmol       Date:  2009-02-20       Impact factor: 2.379

3.  Influence of N(2)O(4) on multifocal electroretinogram in winstar mice.

Authors:  Lian-Na Hu; Chang-Yu Qiu; Hong-Xin Yan; Ling Luo; Jun Zhao; Hui-Ling Guo; Fu-Lin Gao; Zhi-Sheng Li; Nan Ma
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

4.  Spatial differences in corneal electroretinogram potentials measured in rat with a contact lens electrode array.

Authors:  Yelena Krakova; Hadi Tajalli; Sanitta Thongpang; Zahra Derafshi; Tamas Ban; Safa Rahmani; Ashley N Selner; Amani Al-Tarouti; Justin C Williams; John R Hetling
Journal:  Doc Ophthalmol       Date:  2014-09-30       Impact factor: 2.379

5.  Revealing a retinal facilitatory effect with the multifocal ERG.

Authors:  Dylan Vatcher; Allison L Dorfman; Youjia Shen; Jia Yue You; Vincent Sun; Ayesha Khan; Robert C Polomeno; Pierre Lachapelle
Journal:  Doc Ophthalmol       Date:  2019-01-31       Impact factor: 2.379

Review 6.  [Progressive maculopathy despite discontinuation of chloroquine treatment-multimodal imaging and review of the literature].

Authors:  A Rickmann; S Al-Nawaiseh; L Ramirez; S Röhrig; M Ladewig; P Szurman; G Szurman
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

7.  Influence of chloroquine intake on the multifocal electroretinogram in patients with and without maculopathy.

Authors:  Richard Bergholz; Klaus Rüther; Jan Schroeter; Christoph von Sonnleithner; Daniel J Salchow
Journal:  Doc Ophthalmol       Date:  2015-01-31       Impact factor: 2.379

8.  Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.

Authors:  Susann Missner; Ulrich Kellner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

9.  Chloroquine and hydroxychloroquine retinopathy-related risk factors in a Turkish cohort.

Authors:  Sevil Ari Yaylali; Fariz Sadigov; Hasan Erbil; Asiye Ekinci; Aylin Ardagil Akcakaya
Journal:  Int Ophthalmol       Date:  2013-03-02       Impact factor: 2.031

10.  Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Hande Husniye Telek; Nilufer Yesilirmak; Gulten Sungur; Yaprak Ozdemir; Nesibe Karahan Yesil; Firdevs Ornek
Journal:  Doc Ophthalmol       Date:  2017-08-29       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.